logo
Sign in

NMLSF Stock Price, Chart, Stats & News

Restart Life Sciences Corp.
Save

Restart Life Sciences Corp. (NMLSF) does not currently pay a dividend.

1.81M
Market cap
–
Current P/E
–
Forward P/E

NMLSF chart

About

Health care
Sector
Biotechnology
Industry

Restart Life Sciences Corp., through its subsidiaries, operates as a biotechnology company worldwide. It engages in developing natural remedies specifically tailored for individuals on the autism spectrum; health-related foods that promote both mind and body wellness for healthy living, as well as psilocybin clinical trial for fragile X syndrome. The company has collaboration with the University of Manitoba's Richardson Centre for food technology and research (RCFTR) to support a series of food-related scientific studies.

Similar securities

Based on sector and market capitalization

Report issue